Post Views: 0
EU Trans Reg ID: 221589017973-83
The new EU Clinical Trials Regulation (Regulation No. 536/2014) will come into force in 2019. The regulation aims at streamlining and simplifying rules in order to revive research activity in Europe, for example by introducing a unified application process through a single EU portal for cross-border trials.
Simplification of rules include:
For more information and for accessing documents in your language:
PRIME
Early contact and third party intervention in marketing authorisation applications
EU Transparency Register ID 221589017973-83
Demonstrating our commitment to transparency
The Register of Interest Representatives is part of the European Transparency Initiative of the European Commission.
It aims to inform citizens about which interest group or organisation is lobbying the European institutions
and the amount of resources being used to this end.